We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

37 hedge funds and large institutions have $12.6M invested in Microbot Medical in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $8.18M → $12.6M (+$4.39M)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 36 → 37 (+1)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

Holders
37
Holders Change
+1
Holders Change %
+2.78%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
+$713K
2
BIT
BlackRock Institutional Trust
California
+$143K
3
Jane Street
Jane Street
New York
+$111K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$108K
5
BCM
Bourgeon Capital Management
Connecticut
+$64.6K

Top Sellers

Rank Fund Capital Flow
1
CLOS
Compagnie Lombard Odier SCmA
Switzerland
-$443K
2
IHM
Iguana Healthcare Management
New York
-$335K
3
Morgan Stanley
Morgan Stanley
New York
-$104K
4
VKH
Virtu KCG Holdings
New York
-$99.2K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$41.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$5.88M +$143K +62 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.04M +$53.1K +23 +4%
SFM
3
Sphera Funds Management
Israel
$1.01M +$713K +309 New
BCM
4
Bourgeon Capital Management
Connecticut
$552K +$64.6K +28 +20%
PA
5
Perceptive Advisors
New York
$551K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$424K – – –
BFA
7
BlackRock Fund Advisors
California
$333K +$6.92K +3 +3%
Jane Street
8
Jane Street
New York
$271K +$111K +48 +141%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$230K +$108K +47 +204%
Northern Trust
10
Northern Trust
Illinois
$185K – – –
VKH
11
Virtu KCG Holdings
New York
$170K -$99.2K -43 -45%
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$161K – – –
ICAS
13
Investors Capital Advisory Services
Massachusetts
$115K -$11.5K -5 -13%
Nomura Holdings
14
Nomura Holdings
Japan
$81K +$4.61K +2 +9%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$69K – – –
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$59K +$11.5K +5 +38%
Morgan Stanley
17
Morgan Stanley
New York
$42K -$104K -45 -78%
GC
18
Guggenheim Capital
Illinois
$42K -$2.31K -1 -7%
CLOS
19
Compagnie Lombard Odier SCmA
Switzerland
$41K -$443K -192 -94%
BA
20
BlackRock Advisors
Delaware
$40K – – –
Commonwealth Equity Services
21
Commonwealth Equity Services
Massachusetts
$34K – – –
CS
22
Credit Suisse
Switzerland
$32K – – –
Goldman Sachs
23
Goldman Sachs
New York
$28K +$20.8K +9 New
PNC Financial Services Group
24
PNC Financial Services Group
Pennsylvania
$22K -$41.5K -18 -72%
U
25
UBS
Switzerland
$22K +$2.31K +1 +17%
1
2

MBOT Hedge Fund Activity: Q2 2014 in Review

37 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2014, worth a combined $12.6M — up 54% from $8.18M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MBOT positions and 4 closed out — a net gain of 1 holder — while 9 added to existing stakes and 10 trimmed.

The largest buyer was Sphera Funds Management, opening a new position worth an estimated $713K. The largest seller was Compagnie Lombard Odier SCmA, cutting an estimated $443K.

  • 37 institutional investors held Microbot Medical (MBOT) as of Q2 2014, up from 36 in Q1 2014.
  • Funds reported $12.6M of Microbot Medical stock for Q2 2014, up 54% quarter-over-quarter.
  • 5 funds opened new Microbot Medical positions in Q2 2014 and 4 closed out, a net change of +1 holder.
  • The largest Microbot Medical buyer in Q2 2014 was Sphera Funds Management, an estimated $713K added.
  • The largest Microbot Medical seller in Q2 2014 was Compagnie Lombard Odier SCmA, an estimated $443K sold.

Based on aggregated 13F filings for Q2 2014.